Pan-Cancer Genomic and Clinical Landscape of Human Deubiquitinases Identifies Recurrent Cancer-Associated DUBs and Candidate Substrate Networks

Deubiquitinases (DUBs) are key regulators of ubiquitin-mediated signaling and control essential cellular processes such as protein turnover, DNA repair, apoptosis, and immune responses. Despite their importance in cancer, a comprehensive multi-omics characterization of DUBs across malignancies remains limited. Here, we performed an integrated pan-cancer analysis using transcriptomic, genomic, and clinical data from The Cancer Genome Atlas (TCGA), combined with experimentally validated DUB–substrate interactions and public proteomic datasets from gastric cancer, esophageal cancer, and glioma. Our analysis revealed substantial heterogeneity in DUB expression across cancers, with distinctive relative expression profiles of DUBs including USP7, USP10, USP11, USP14, USP22, OTUB1, and BAP1. Comparative analysis of ESCA and STAD identified eighteen shared cancer-enriched DUBs, suggesting overlap in their relative expression patterns in upper gastrointestinal cancers. Genomic profiling showed frequent copy-number amplifications (USP13, OTUD7B, EIF3H, USP21, USP36) and deletions (OTUD7A, USP2, USP28, USP19, BAP1), while mutation analysis highlighted USP34, USP9X, USP29, USP24, and USP26 as genes with high observed mutation counts. Survival analysis identified several prognostic DUBs, including USP1, USP4, OTUD7A, DESI2, PSMD14, and UCHL1. Integration of public proteomic datasets with curated DUB–substrate interactions highlighted candidate associations with pathways related to NF-κB signaling, apoptosis, cell-cycle regulation, and DNA damage response. Several DUBs, including USP7, USP10, USP11, USP14, and USP22, showed high connectivity within the constructed networks, prioritizing them for further functional investigation. Overall, this study provides a comprehensive pan-cancer atlas of DUB alterations and highlights candidate DUBs and pathways with potential diagnostic, prognostic, and therapeutic relevance.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-18
DOI
https://doi.org/10.3390/ijms272210366
Primary Topic
Ubiquitin and proteasome pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pan-Cancer Genomic and Clinical Landscape of Human Deubiquitinases Identifies Recurrent Cancer-Associated DUBs and Candidate Substrate Networks

Kandel Codi Jalaluddin Akbar, Srilatha Marate, Mohd Altaf Najar, Prashant Kumar Modi et al.
3 links
International Journal of Molecular Sciences
Ubiquitin and proteasome pathways
article

Pan-Cancer Genomic and Clinical Landscape of Human Deubiquitinases Identifies Recurrent Cancer-Associated DUBs and Candidate Substrate Networks

Kandel Codi Jalaluddin Akbar, Srilatha Marate, Mohd Altaf Najar, Prashant Kumar Modi, Nikita Choudhary, Sahla Abdulsalam, Vignesh Ravi Nayak
article en

Abstract

Deubiquitinases (DUBs) are key regulators of ubiquitin-mediated signaling and control essential cellular processes such as protein turnover, DNA repair, apoptosis, and immune responses. Despite their importance in cancer, a comprehensive multi-omics characterization of DUBs across malignancies remains limited. Here, we performed an integrated pan-cancer analysis using transcriptomic, genomic, and clinical data from The Cancer Genome Atlas (TCGA), combined with experimentally validated DUB–substrate interactions and public proteomic datasets from gastric cancer, esophageal cancer, and glioma. Our analysis revealed substantial heterogeneity in DUB expression across cancers, with distinctive relative expression profiles of DUBs including USP7, USP10, USP11, USP14, USP22, OTUB1, and BAP1. Comparative analysis of ESCA and STAD identified eighteen shared cancer-enriched DUBs, suggesting overlap in their relative expression patterns in upper gastrointestinal cancers. Genomic profiling showed frequent copy-number amplifications (USP13, OTUD7B, EIF3H, USP21, USP36) and deletions (OTUD7A, USP2, USP28, USP19, BAP1), while mutation analysis highlighted USP34, USP9X, USP29, USP24, and USP26 as genes with high observed mutation counts. Survival analysis identified several prognostic DUBs, including USP1, USP4, OTUD7A, DESI2, PSMD14, and UCHL1. Integration of public proteomic datasets with curated DUB–substrate interactions highlighted candidate associations with pathways related to NF-κB signaling, apoptosis, cell-cycle regulation, and DNA damage response. Several DUBs, including USP7, USP10, USP11, USP14, and USP22, showed high connectivity within the constructed networks, prioritizing them for further functional investigation. Overall, this study provides a comprehensive pan-cancer atlas of DUB alterations and highlights candidate DUBs and pathways with potential diagnostic, prognostic, and therapeutic relevance.

International Journal of Molecular SciencesVol. 27(22)
Yenepoya University (IN), Yenepoya Research Centre (IN)
Good health and well-being
Ubiquitin and proteasome pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon